Supernus Pharmaceuticals SUPN Q1 2026 Earnings Robust EPS Beat Overshadowed by Mild Share Decline CBAN Q1 2026 Earnings Earnings Miss Weighs on Results Despite Modest Share Price Gain NEON Q1 2026 Earnings EPS Misses Estimates Amid Elevated Operating Costs Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure MITK Q1 2026 Earnings EPS Surpasses Estimates on Strong Operating Performance BL Q1 2026 Earnings EPS Surpasses Expectations by Over 21